Search Results - "el‐Shami, Khaled"

Refine Results
  1. 1
  2. 2

    Nonbacterial Thrombotic Endocarditis in Cancer Patients: Pathogenesis, Diagnosis, and Treatment by elShami, Khaled, Griffiths, Elizabeth, Streiff, Michael

    Published in The oncologist (Dayton, Ohio) (01-05-2007)
    “…Learning Objectives Enumerate procoagulant factors present in malignancy and the risk for thromboembolic events. Describe the morbidity associated with…”
    Get full text
    Journal Article
  3. 3

    Arsenic trioxide for acute promyelocytic leukemia in a patient on chronic hemodialysis by Tinajero, Jose, El-Shami, Khaled, Wu, Xiaojun, Smith, B. Douglas, Newman, Matthew J.

    Published in Leukemia research reports (01-01-2022)
    “…Acute promyelocytic leukemia (APL) is a rare acute leukemia generally considered curable with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO). Some…”
    Get full text
    Journal Article
  4. 4

    A rare breed: Wild-type braf and ighv expression in a 29 year old lady with classical hairy cell leukemia by Hossain, Aneesha, Rafei, Hind, Jariwala, Amar, El-Shami, Khaled

    Published in Leukemia research reports (2017)
    “…Abstract The V600 BRAF mutation has been described as a key mutation in the pathogenesis of classical hairy cell leukemia ( c -HCL) cases without expression of…”
    Get full text
    Journal Article
  5. 5

    MHC class I‐restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope by elShami, Khaled, Tirosh, Boaz, Bar‐Haim, Erez, Carmon, Lior, Vadai, Ezra, Fridkin, Mati, Feldman, Michael, Eisenbach, Lea

    Published in European journal of immunology (01-10-1999)
    “…Epitope spreading is a process whereby epitopes distinct from and non‐cross‐reactive with an inducing epitope become targets of an evolving immune response…”
    Get full text
    Journal Article
  6. 6

    Induction of antitumor immunity with modified autologous cells expressing membrane-bound murine cytokines by el-Shami, K M, Tzehoval, E, Vadai, E, Feldman, M, Eisenbach, L

    Published in Journal of interferon & cytokine research (01-12-1999)
    “…Development of cytokine gene-modified autologous tumor vaccines must take into account the strictly paracrine physiology of cytokines whose expression at the…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Phase II study: Induction chemotherapy & transoral surgery as definitive tx for locally advanced oropharyngeal squamous cell carcinoma (OPSCC)—A novel approach by Siegel, Robert S., Rafei, Hind, Joshi, Arjun, El-Shami, Khaled, Taheri, Reza, Guebre-Xabiher, Hiwot, Sadeghi, Nader

    Published in Journal of clinical oncology (20-05-2017)
    “…Abstract only 6078 Background: The standard of care for OPSCC includes chemoradiation (CRT) or surgery with adjuvant radiation (RT). However, RT is associated…”
    Get full text
    Journal Article
  9. 9

    Antimetastatic vaccination against Lewis lung carcinoma with autologous tumor cells modified to express murine interleukin 12 by Popovic, D, El-Shami, K M, Vadai, E, Feldman, M, Tzehoval, E, Eisenbach, L

    Published in Clinical & experimental metastasis (01-10-1998)
    “…Interleukin 12 (IL-12) is a disulfide-linked heterodimer molecule produced predominantly by professional antigen presenting cells. It promotes the induction of…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Phase II Study of Obatoclax Mesylate (GX15-070), a Small-Molecule BCL-2 Family Antagonist, for Patients With Myelofibrosis by Parikh, Sameer A, Kantarjian, Hagop, Schimmer, Aaron, Walsh, William, Asatiani, Ekatherine, El-Shami, Khaled, Winton, Elliott, Verstovsek, Srdan

    Published in Clinical lymphoma, myeloma and leukemia (01-08-2010)
    “…Abstract Background Myelofibrosis (MF) is a disease characterized by the overexpression of the antiapoptotic BCL-2 family of proteins (eg, BCL-XL and MCL-1)…”
    Get full text
    Journal Article
  13. 13
  14. 14

    FLT3 inhibitors in acute myeloid leukemia by el-Shami, Khaled, Stone, Richard M, Smith, B Douglas

    Published in Expert review of hematology (01-12-2008)
    “…The fms-like tyrosine kinase 3 (FLT3) plays an important role in both normal and malignant hematopoiesis. Activating mutations in the FLT3 receptor can be…”
    Get more information
    Journal Article
  15. 15

    Antitumor vaccination using peptide based vaccines by Eisenbach, Lea, Bar-Haim, Erez, El-Shami, Khaled

    Published in Immunology letters (15-09-2000)
    “…Cytotoxic T Lymphocytes (CTLs) recognize Major Histocompatibility Complex (MHC) class I in complex with peptides. Peptides derived from Tumor Associated…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Induction of antitumor immunity by proteasome‐inhibited syngeneic fibroblasts pulsed with a modified TAA peptide by ElShami, Khaled M., Tirosh, Boaz, Popovic, Dan, Carmon, Lior, Tzehoval, Esther, Vadai, Ezra, Feldman, Michael, Eisenbach, Lea

    Published in International journal of cancer (15-01-2000)
    “…CTLs specific for tumor antigens play a major role in immunity against cancer. Improved binding affinity of putative TAA peptides could enhance the in vivo…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Induction of antitumor immunity by proteasome-inhibited syngeneic fibroblasts pulsed with a modified TAA peptide by EL-SHAMI, K. M, TIROSH, B, POPOVIC, D, CARMON, L, TZEHOVAL, E, VADAI, E, FELDMAN, M, EISENBACH, L

    Published in International journal of cancer (15-01-2000)
    “…CTLs specific for tumor antigens play a major role in immunity against cancer. Improved binding affinity of putative TAA peptides could enhance the in vivo…”
    Get full text
    Journal Article